| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 17, 2026 | Option exercise(M) | 822 | $6.52 | $5K | 38K |
| Aug 17, 2026 | Option exercise(M) | 1K | $7.51 | $8K | 39K |
| Aug 17, 2026 | Option exercise(M) | 2K | $8.63 | $19K | 41K |
| Aug 17, 2026 | Sell(S) | 5K | $26.18 | $124K | 36K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 17, 2026 | Option exercise(M) | 822 | — | $0 | 7K |
| Aug 17, 2026 | Option exercise(M) | 1K | — | $0 | 9K |
| Aug 17, 2026 | Option exercise(M) | 2K | — | $0 | 20K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-058008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Arcutis Biotherapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.